{"id":297415,"date":"2023-09-12T08:38:28","date_gmt":"2023-09-12T13:38:28","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=297415"},"modified":"2023-09-12T15:19:29","modified_gmt":"2023-09-12T20:19:29","slug":"transgender-services-increase-minors-countries-brakes","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/transgender-services-increase-minors-countries-brakes\/","title":{"rendered":"Transgender services increase among minors, as some countries put on the brakes"},"content":{"rendered":"
<\/div>

Transgender confusion is a growing epidemic, especially among minor children who could be manipulated by profit seeking agencies like Planned Parenthood and others. Planned Parenthood openly promotes<\/a> this to minors and is among the organizations<\/a> praising legislation seeking<\/a>\u00a0to codify access to transgender services by\u00a0shielding those providers<\/a> \u2014 much like they did for abortion. In addition, abortion facilities<\/a> across the United States are also cashing in on the proliferation of transgender confusion, with some openly advertising “gender-affirming” services to minors.<\/p>\n

Today, the number of young people accessing transgender services is on the rise, which might explain why a growing number of parents are addressing the transgender agenda and pressuring states<\/a> to pass legislation to protect minor children.<\/p>\n

General Statistics\u00a0<\/strong><\/p>\n

In 2022,<\/a> the Williams Institute claimed that roughly 1.4% of transgender-identifying individuals (about 300,000 youth) are between the ages of 13 to 17 in the U.S. The report found that young teens are a growing demographic of the transgender community, writing that “Youth ages 13 to 17 comprise a larger share of the transgender-identified population than…previously estimated, currently comprising about 18% of the transgender-identified population in the U.S., up from 10% previously.”<\/p>\n

The Human Rights Campaign (HRC) claims online<\/a> that, “there are more than 300,000<\/strong> high school-aged (ages 13-17) transgender youth in the United States today.” Adding that many “trans youth (45<\/strong>.4%<\/strong>, or 136,300) live in states in which transgender youth have lost access to, or are at risk of losing access to, gender-affirming care.” In addition, HRC claimed “Three in ten (35.1<\/strong>%<\/strong> or 105,200 total) trans youth aged 13-17 live in states that have passed bans on gender affirming care.”<\/p>\n

It should be noted, however, that this “care” is not restricted for adults.<\/p>\n

\"Transgender

Trans identifying adults and youth The Williams Institute (June 2022)<\/p><\/div>\n

“In 2021, about 42,000 children and teens across the United States received a diagnosis of gender dysphoria, nearly triple the number in 2017,” according to data<\/a> Komodo [Health] compiled for Reuters<\/a>. This represents a 64% increase from the 15,172 reported in 2017 and a 70% increase between just 2020 (24,847) and 2021 (42,167).<\/p>\n

“Gender dysphoria is defined as the distress caused by a discrepancy between a person\u2019s gender identity and the one assigned to them at birth,” Reuters reported<\/a>.<\/p>\n

“Komodo\u2019s analysis draws on full or partial health insurance claims for about 330 million U.S. patients over the five years from 2017 to 2021, including patients covered by private health plans and public insurance like Medicaid. The data include roughly 40 million patients annually, ages 6 through 17, and comprise health insurance claims that document diagnoses and procedures administered by U.S. clinicians and facilities,” Reuters added.<\/p>\n

“Overall, the [Komodo] analysis found that at least 121,882 children ages 6 to 17 were diagnosed with gender dysphoria from 2017 through 2021. Reuters found similar trends when it requested state-level data on diagnoses among children covered by Medicaid, the public insurance program for lower-income families,” Reuters wrote.<\/p>\n

Things like “puberty blockers,” hormones, and surgery used among children with gender dysphoria have not been well studied.<\/p>\n

\"Adolescent

Adolescent youth: puberty blockers, hormone therapy, and top surgery GAC care (Graphs Per Reuters)<\/p><\/div>\n

Use of Drugs Referred to as “Puberty Blockers”<\/strong><\/p>\n

Children diagnosed with gender dysphoria can begin medical interventions such as “puberty-blocking medications,” claimed<\/a> Reuters, but these experimental drugs for children identifying as transgender do not begin until the onset of puberty. Blockers, as they are called, are actually drugs that were formerly used<\/a> in the chemical castration of violent rapists. They work by suppressing estrogen and testosterone.<\/p>\n

“Before puberty, neither the Endocrine Society<\/a>,\u00a0American Academy of Pediatrics<\/a>, nor the\u00a0World Professional Association for Transgender Health<\/a> recommend any hormonal or surgical interventions,” HealthNews Florida reported<\/a>.<\/p>\n

According to the NYT<\/a>, “They were first tested on children with gender dysphoria in the Netherlands in the 1990s<\/a>. The Dutch researchers published their\u00a0first study<\/a> on 70 children in 2011,” NYT claimed. The study claimed adolescents reported a decrease in depression and anxiety after taking the drugs.<\/p>\n

“But a British study of Tavistock patients\u00a0published in 2021<\/a> showed that blockers had no effect on children\u2019s scores on psychological tests,” NYT added<\/a>.<\/p>\n

According to Abigail Shrier, a journalist and author of the 2020 book, “Irreversible Damage: The Transgender Craze Seducing Our Daughters,” as “Dutch researchers were beginning to raise concerns about puberty blockers, American health providers discovered it. In 2007, the Dutch Protocol arrived at Boston Children\u2019s Hospital, one of the preeminent children\u2019s hospitals in the nation. It would soon become the leading course of treatment for all transgender-identified children and adolescents in the United States.”<\/p>\n

“These drugs, known as GnRH<\/a> agonists suppress the release of the sex hormones testosterone and estrogen. The U.S. Food and Drug Administration has approved the drugs [in 1985<\/a>] to treat prostate cancer, endometriosis and central precocious puberty, but not gender dysphoria. Their off-label use in gender-affirming care, while legal, lacks the support of clinical trials to establish their safety for such treatment,” Reuters wrote<\/a>.<\/p>\n

And yet, even the abortion industry \u2014\u00a0 which objects to the off-label use of the hormone progesterone to counteract the effects of the abortion pill (often referred to as “abortion pill reversal”), supports and participates in the administration of unstudied sex hormones to trans-identifying children.<\/p>\n

“Over the last five years, there were at least 4,780 adolescents who started on puberty blockers and had a prior gender dysphoria diagnosis,” Reuters wrote. The numbers are likely undercounted, Reuters claimed, because “they didn\u2019t include treatment that wasn\u2019t covered by insurance and were limited to pediatric patients with a gender dysphoria diagnosis.”<\/p>\n

Komodo’s data for Reuters indicates that the number of adolescents put on “puberty blockers” increased over 119% from 633 in 2017 to 1,390 in 2021.<\/p>\n

Recently, the National Health Service of England announced “it would limit the use of puberty-suppressing drugs<\/a> to children enrolled in clinical trials… A document explaining the agency\u2019s reasoning stated that<\/a> ‘there is not enough evidence to support their safety or clinical effectiveness as a routinely available treatment,’\u201d NYT noted.<\/p>\n